Bank Of New York Mellon Corp Zomedica Corp. Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.16 - $0.25 $92,862 - $145,097	580,391 New	580,391 $92,000
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.34 $198 - $337	-992 Reduced 0.17%	581,518 $128,000
Q1 2022 May 11, 2022	SELL	$0.28 - $0.4 $101,653 - $145,218	-363,047 Reduced 38.4%	582,510 $196,000
Q4 2021 Feb 11, 2022	BUY	$0.31 - $0.58 $117,485 - $219,810	378,984 Added 66.89%	945,557 $290,000
Q3 2021 Nov 12, 2021	BUY	$0.46 - $0.81 $67,328 - $118,556	146,366 Added 34.83%	566,573 $297,000
Q2 2021 Aug 11, 2021	SELL	$0.72 - $1.46 $41,834 - $84,831	-58,104 Reduced 12.15%	420,207 $348,000
Q1 2021 May 13, 2021	BUY	$0.35 - $2.7 $167,408 - $1.29 Million	478,311 New	478,311 $755,000

80.9M

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.